Targeted Immunotherapy for Chronic Hepatitis B (CHB-TI)

Time: 2:30 pm
day: Day Two

Details:

  • Importance of de novo induction of antigen specific adaptive immunity to CHB
  • Development of novel CHB-TI regimens
  • Status of CHB-TI clinical program and development of synergistic combination modalities

Speakers: